Insider Transactions in Q4 2021 at Galectin Therapeutics Inc (GALT)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 31
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,052
+2.62%
|
$16,104
$2.07 P/Share
|
Dec 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,407
+2.48%
|
$14,814
$2.25 P/Share
|
Dec 06
2021
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
10,000
+9.55%
|
$20,000
$2.31 P/Share
|
Dec 02
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.37 P/Share
|
Nov 30
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,337
+2.18%
|
$12,674
$2.63 P/Share
|
Nov 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,828
+2.05%
|
$11,656
$2.86 P/Share
|
Nov 01
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.19 P/Share
|
Oct 29
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,258
+1.9%
|
$15,774
$3.17 P/Share
|
Oct 29
2021
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
2,000
+4.76%
|
$6,000
$3.17 P/Share
|
Oct 21
2021
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
2,000
+5.0%
|
$6,000
$3.19 P/Share
|
Oct 19
2021
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
3,000
+7.69%
|
$9,000
$3.37 P/Share
|
Oct 15
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.37 P/Share
|
Oct 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,946
+1.82%
|
$14,838
$3.37 P/Share
|
Oct 04
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.62 P/Share
|